Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Cambridgeshire based CEO’ operating in the Pharmaceutical space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Hannah Sore
Founder and CEO of PharmEnable
Follow Hannah Sore:
About PharmEnable: PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.
Shravane Balabasqer
Founder | CEO of Carbon Analytics
Follow Shravane Balabasqer:
About Carbon Analytics: A granular asset focused carbon intelligence & offsetting platform for active industrial decarbonisation across the value chain.
Jennifer Barnett
CEO of Monument Therapeutics
Follow Jennifer Barnett:
About Cambridge Cognition, Monument Therapeutics: Monument Therapeutics develops products to treat serious diseases of the central nervous system.
Michael Chen
Co-founder and CEO of Nuclera
Michael Chen is the Co-founder and CEO at Nuclera.
Follow Michael Chen:
About Nuclera: Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
Ben Pellegrini
Chief Executive Officer of Intellegens
Follow Ben Pellegrini:
About Intellegens: Cambridge spin out using Deep Learning to train on big, incomplete data. Currently working in drug discovery and material design.
Frank F. Craig
CEO of Sphere Fluidics
Dr Frank F. Craig has around 15 years of international, general management experience gained from GlaxoSmithKline, Amersham Biosciences (as a Vice-President of R&D) and several start-up firms. He was responsible for managing product development of Green Fluorescent Protein (first identified by the 2008 Nobel Prize Winners for Chemistry) and many other cell-based products and services for the Life Sciences industry. Frank was a (co)-Founder of Aurora Biosciences (San Diego, USA), which had a peak market cap. of £1.8 billion and was acquired by Vertex Pharmaceuticals for £420 million. He was also a co-Founder and CEO of Smart Holograms (Cambridge, UK) – named as the UK’s Fastest Growing Company. Frank has raised £22 million in Private Equity, £25 million via an IPO on NASDAQ and has delivered many commercial partnerships with global Life Sciences and Energy firms – resulting in recorded deal values of £180 million. He has been a Board Director of Smart Holograms and TekCel (Hopkinton, USA), and helped form Sphere Fluidics before becoming its CEO in May 2010. He has a PhD in Cell Biology and Microbiology from Glasgow University and an MBA from Warwick Business School.
Follow Frank F. Craig:
About BioChannel Partners, Sphere Fluidics: Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services.
Joanna Burnett
Co-founder and CEO of GPrX Data
Follow Joanna Burnett:
About GPrX Data: GPrX Data translates NHS practice level prescribing data into easily-reviewed intelligence.
